NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Collection of Blood from Patients with Cancer, Other Tumors, or Tumor Predisposition Syndromes for Analysis of Genetic Differences in Drug Disposition

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

11-C-0242

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 3 Years
Max Age: N/A

Referral Letter Required

Yes

Population Exclusion(s)

None

Keywords

Pharmacogenetics;
Pharmacokinetics;
Pharmacodynamics;
Clinical Outcome;
Drug Metabolism and Transport;
Natural History

Recruitment Keyword(s)

Cancer

Condition(s)

Prostate Cancer;
Breast Cancer;
Lung Cancer;
Ovarian Cancer;
Lymphoma

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Cancer Institute

Background:

- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.

Objectives:

- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.

Eligibility:

- Individuals with cancer who are being treated at the National Cancer Institute.

Design:

- Participants will provide a blood sample for study.

- Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample.

- If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Patients with cancer, other tumors, or tumor predisposition syndromes currently enrolled in NIH intramural research program therapeutic trials.

Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.

Age >= 3 years old

EXCLUSION CRITERIA:

N/A


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

William D. Figg, Pharm.D.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 5A01
10 Center Drive
Bethesda, Maryland 20892
(240) 760-6179
figgw@mail.nih.gov

Deneise Francis, R.N.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 13N222
10 Center Drive
Bethesda, Maryland 20892
(240) 858-3974
deneise.francis@nih.gov

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
1-888-NCI-1937
ncimo_referrals@mail.nih.gov

Clinical Trials Number:

NCT01441089

--Back to Top--

NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Collection of Blood from Patients with Cancer, Other Tumors, or Tumor Predisposition Syndromes for Analysis of Genetic Differences in Drug Disposition

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

11-C-0242

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 3 Years
Max Age: N/A

Referral Letter Required

Yes

Population Exclusion(s)

None

Keywords

Pharmacogenetics;
Pharmacokinetics;
Pharmacodynamics;
Clinical Outcome;
Drug Metabolism and Transport;
Natural History

Recruitment Keyword(s)

Cancer

Condition(s)

Prostate Cancer;
Breast Cancer;
Lung Cancer;
Ovarian Cancer;
Lymphoma

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Cancer Institute

Background:

- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.

Objectives:

- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.

Eligibility:

- Individuals with cancer who are being treated at the National Cancer Institute.

Design:

- Participants will provide a blood sample for study.

- Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample.

- If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Patients with cancer, other tumors, or tumor predisposition syndromes currently enrolled in NIH intramural research program therapeutic trials.

Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.

Age >= 3 years old

EXCLUSION CRITERIA:

N/A


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

William D. Figg, Pharm.D.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 5A01
10 Center Drive
Bethesda, Maryland 20892
(240) 760-6179
figgw@mail.nih.gov

Deneise Francis, R.N.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 13N222
10 Center Drive
Bethesda, Maryland 20892
(240) 858-3974
deneise.francis@nih.gov

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
1-888-NCI-1937
ncimo_referrals@mail.nih.gov

Clinical Trials Number:

NCT01441089

--Back to Top--